BL-8040 Addition to Consolidation Therapy in AML Patients

Clinical trial NCT02502968 · UNKNOWN

Trial details

NCT number: NCT02502968
Sponsor: Dr. Petra Tschanter
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2015-09-01
Primary completion: 2018-07-01
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.